Browse > Article
http://dx.doi.org/10.3345/kjp.2018.61.7.217

Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis  

Gursoy, Semra (Department of Pediatrics, Kanuni Sultan Suleyman Training and Research Hospital)
Kockar, Tuba (Department of Pediatrics, Kanuni Sultan Suleyman Training and Research Hospital)
Atik, Sezen Ugan (Department of Pediatrics, Kanuni Sultan Suleyman Training and Research Hospital)
Onal, Zerrin (Department of Pediatric Gastroenterology, Kanuni Sultan Suleyman Training and Research Hospital)
Onal, Hasan (Department of Pediatric Metabolic Disease, Kanuni Sultan Suleyman Training and Research Hospital)
Adal, Erdal (Department of Pediatric Endocrinology and Metabolism, Kanuni Sultan Suleyman Training and Research Hospital)
Publication Information
Clinical and Experimental Pediatrics / v.61, no.7, 2018 , pp. 217-220 More about this Journal
Abstract
Purpose: Type 1 diabetes mellitus (T1DM) is a chronic and immune-mediated disease, which is characterized by the progressive destruction of pancreatic beta cells. T1DM precipitates in genetically susceptible individuals through environmental factors. In this study, we aimed to evaluate the impact of autoimmunity and intestinal colonization of Candida albicans on the development of T1DM. Methods: Forty-two patients newly diagnosed with T1DM and 42 healthy subjects were included in this monocentric study. The basic and clinical characteristics of the patients were recorded. T1DM-, thyroid-, and celiac-associated antibodies were evaluated. Stool cultures for C. albicans were performed to assess whether or not gut integrity was impaired in patients with T1DM. Results: The evaluation of T1DM- and thyroid-associated antibodies showed that the prevalences of islet cell antibodies and antithyroperoxidase positivity were higher in the study patients than in the patients in the control group. Furthermore, the direct examination and culture of fresh stool samples revealed that 50% of the patients with T1DM and 23.8% of the control subjects had fungi (C. albicans). Conclusion: Through this study, we suggest that the presence of intestinal C. albicans colonization at the time of the diagnosis of T1DM may indicate impairment of normal intestinal microbiota. We also suggest that there may be a tendency of T1DM in patients with a high prevalence of intestinal C. albicans.
Keywords
Type 1 diabetes mellitus; Intestinal microbiota; Candida albicans;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Graham S, Courtois P, Malaisse WJ, Rozing J, Scott FW, Mowat AM. Enteropathy precedes type 1 diabetes in the BB rat. Gut 2004;53:1437-44.   DOI
2 Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45:926-33.   DOI
3 Bingley PJ. Interactions of age, islet cell antibodies, insulin autoanti- bodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study. Diabetes 1996;45:1720-8.   DOI
4 Kakleas K, Paschali E, Kefalas N, Fotinou A, Kanariou M, Karayianni C, et al. Factors for thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Ups J Med Sci 2009;114:214-20.   DOI
5 Szaflarska-Poplawska A. Coexistence of coeliac disease and type 1 diabetes. Prz Gastroenterol 2014;9:11-7.
6 Barera G, Bonfanti R, Viscardi M, Bazzigaluppi E, Calori G, Meschi F, et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 2002;109:833-8.   DOI
7 Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006;55:1443-9.   DOI
8 Carratù R, Secondulfo M, de Magistris L, Iafusco D, Urio A, Carbone MG, et al. Altered intestinal permeability to mannitol in diabetes mellitus type I. J Pediatr Gastroenterol Nutr 1999;28:264-9.   DOI
9 Westerholm-Ormio M, Vaarala O, Pihkala P, Ilonen J, Savilahti E. Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 2003;52:2287-95.   DOI
10 Secondulfo M, Iafusco D, Carratù R, deMagistris L, Sapone A, Generoso M, et al. Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Dig Liver Dis 2004;36:35-45.   DOI
11 Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 2006;49:2824-7.   DOI
12 Sonoyama K, Miki A, Sugita R, Goto H, Nakata M, Yamaguchi N. Gut colonization by Candida albicans aggravates inflammation in the gut and extra-gut tissues in mice. Med Mycol 2011;49:237-47.   DOI
13 Kweon MN, Yamamoto M, Kajiki M, Takahashi I, Kiyono H. Systemically derived large intestinal CD4(+) Th2 cells play a central role in STAT6-mediated allergic diarrhea. J Clin Invest 2000;106:199-206.   DOI
14 Roesch LF, Lorca GL, Casella G, Giongo A, Naranjo A, Pionzio AM, et al. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J 2009;3:536-48.   DOI
15 Grönlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999;28:19-25.   DOI
16 Forsythe SJ. The microbiology of safe food. Chichester (UK): Willey-Blackwell, 2010:148.
17 Soyucen E, Gulcan A, Aktuglu-Zeybek AC, Onal H, Kiykim E, Aydin A. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatr Int 2014;56:336-43.   DOI
18 Jonsson L, Hallstrom I, Lundqvist A. "The logic of care" - parents' perceptions of the educational process when a child is newly diagnosed with type 1 diabetes. BMC Pediatr 2012;12:165.
19 Lebovitz HE. Diagnosis and classification of diabetes mellitus. In: Lebovitz HE, editor. Therapy for diabetes mellitus and related disorders. 3rd ed. Alexandria (VA): American Diabetes Association; 1998: 4-7.
20 Zoka A, Muzes G, Somogyi A, Varga T, Szeman B, Al-Aissa Z, et al. Altered immune regulation in type 1 diabetes. Clin Dev Immunol 2013;2013:254874.
21 Alderson P, Sutcliffe K, Curtis K. Children as partners with adults in their medical care. Arch Dis Child 2006;91:300-3.   DOI
22 Rankin D, Cooke DD, Elliott J, Heller SR, Lawton J; UK NIHR DAFNE Study Group. Supporting self-management after attending a structur- ed education programme: a qualitative longitudinal investigation of type 1 diabetes patients' experiences and views. BMC Public Health 2012;12:652.   DOI
23 Akesen E, Turan S, Güran T, Atay Z, Save D, Bereket A. Prevalence of type 1 diabetes mellitus in 6-18-yr-old school children living in Istanbul, Turkey. Pediatr Diabetes 2011;12:567-71.
24 Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001;358:221-9.   DOI
25 Proal AD, Albert PJ, Marshall T. Autoimmune disease in the era of the metagenome. Autoimmun Rev 2009;8:677-81.   DOI
26 Neu J, Reverte CM, Mackey AD, Liboni K, Tuhacek-Tenace LM, Hatch M, et al. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastro- enterol Nutr 2005;40:589-95.   DOI
27 Needell JC, Zipris D. The role of the intestinal microbiome in type 1 diabetes pathogenesis. Curr Diab Rep 2016;16:89.   DOI